111 studies found for:    cholangiocarcinoma AND bile duct cancers | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Photodynamic Therapy (PDT) for Palliation of Cholangiocarcinoma
Conditions: Cholangiocarcinoma;   Biliary Stricture;   Biliary Obstruction;   Bile Duct Cancer
Intervention: Procedure: Photodynamic Therapy
2 Not yet recruiting Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Drug: FOLFIRINOX
3 Unknown  Calcitriol in Advanced Intrahepatic Cholangiocarcinoma
Condition: Advanced Intrahepatic Cholangiocarcinoma
Intervention: Drug: Calcitriol
4 Recruiting CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery
Conditions: Adult Primary Cholangiocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Cholangiocarcinoma of the Extrahepatic Bile Duct;   Cholangiocarcinoma of the Gallbladder;   Localized Unresectable Adult Primary Liver Cancer;   Metastatic Extrahepatic Bile Duct Cancer;   Recurrent Adult Primary Liver Cancer;   Recurrent Extrahepatic Bile Duct Cancer;   Unresectable Extrahepatic Bile Duct Cancer
Intervention: Drug: 6,8-bis(benzylthio)octanoic acid
5 Recruiting Photodynamic Therapy (PDT) Cholangiocarcinoma Registry
Conditions: Unresectable Cholangiocarcinoma;   Biliary Obstruction;   Stent Obstruction;   Biliary Stricture
Intervention: Procedure: Photodynamic Therapy
6 Recruiting Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)
Condition: Hilar Cholangiocarcinoma
Interventions: Drug: Photodynamic therapy-Photofrin;   Procedure: Stenting procedure;   Drug: Chemotherapy regimen Gemcitabine/Cisplatin
7 Unknown  Quality of Life in Patients With Unresectable Hilar Cholangiocarcinoma on Palliative Metallic Stent Versus Plastic Stent
Condition: Unresectable Hilar Cholangiocarcinoma
Intervention: Device: biliary stent
8 Recruiting Next Generation Sequencing in Intrahepatic Cholangiocarcinoma
Condition: Intrahepatic Cholangiocarcinoma
Intervention: Other: exposure to different risk factors and molecular assessment
9 Recruiting Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Drug: Nab-Paclitaxel and Gemcitabine
10 Unknown  Preoperative Biliary Drainage for Resectable Hilar Cholangiocarcinoma
Conditions: Cholangiocarcinoma;   Drainage;   Surgery
Intervention: Procedure: Preoperative biliary drainage
11 Recruiting A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma
Conditions: Unresectable Intrahepatic Cholangiocarcinoma;   Resectable Intrahepatic Cholangiocarcinoma
Interventions: Drug: Gemcitabine;   Drug: Cisplatin;   Procedure: Surgery;   Radiation: Radiation
12 Recruiting Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma
Condition: Cholangiocarcinoma
Interventions: Drug: CX-4945;   Drug: Cisplatin;   Drug: Gemcitabine
13 Recruiting RFA RCT for Pancreatic or Bile Duct Cancer
Conditions: Unresectable Pancreatic Cancer;   Cholangiocarcinoma Non-resectable
Interventions: Procedure: Radiofrequency Ablation using EndoHPB Probe;   Procedure: Stenting only
14 Recruiting International Registry on Cholangiocarcinoma Treatment
Condition: Cholangiocarcinoma
Intervention: Drug: Doxorubicin
15 Recruiting Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients
Condition: Cholangiocarcinoma
Intervention: Other: Observation data collection study.
16 Not yet recruiting Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Drug: Dasatinib
17 Recruiting 90Y Transarterial Radioembolization (TARE) Plus Gemcitabine and Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma
Condition: Intrahepatic Cholangiocarcinoma
Interventions: Device: SIR-Spheres microspheres (Yttrium-90 Microspheres);   Drug: Gemcitabine;   Drug: Cisplatin
18 Unknown  Study of RAD001 in Advanced Cholangiocarcinoma: RADiChol
Condition: Cholangiocarcinoma
Intervention: Drug: RAD001
19 Recruiting Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma
Condition: Hilar Cholangiocarcinoma
Interventions: Procedure: bilateral metal stent insertion;   Procedure: unilateral metal stent insertion
20 Recruiting A Phase I/II Study Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas
Condition: Cholangiocarcinoma
Interventions: Drug: Amphinex and Gemcitabine;   Drug: Gemcitabine and Cisplatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years